Lista de obras -

Accumulation of free oligosaccharides and tissue damage in cytosolic α-mannosidase (Man2c1)-deficient mice.

scientific article published on 18 February 2014

CSF and blood biomarkers for Parkinson's disease

scientific article published on 10 April 2019

Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies

artículo científico publicado en 2009

Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis.

artículo científico publicado en 2017

Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease

artículo científico publicado en 2014

Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients.

artículo científico publicado en 2017

Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy Bodies

artículo científico publicado en 2018

Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis

artículo científico publicado en 2019

Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease.

artículo científico publicado en 2017

Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid

artículo científico publicado en 2014

Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid

artículo científico publicado en 2020

First pilot newborn screening for four lysosomal storage diseases in an Italian region: identification and analysis of a putative causative mutation in the GBA gene

scientific article published on 20 July 2012

Identification of two novel beta-mannosidosis-associated sequence variants: biochemical analysis of beta-mannosidase (MANBA) missense mutations

artículo científico publicado en 2008

Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease

artículo científico publicado en 2020

Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links.

artículo científico publicado en 2016

Lysosomal alpha-mannosidase and alpha-mannosidosis.

artículo científico publicado en 2017

Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies

artículo científico publicado en 2019

Lysosomal enzymes in PD: further evidence is needed

artículo científico publicado en 2014

Molecular cloning and structural organization of the gene encoding the mouse lysosomal di-N-acetylchitobiase (ctbs).

artículo científico publicado en 2008

Novel CSF biomarkers to discriminate FTLD and its pathological subtypes

scientific article published on 07 September 2018

Origin of α-mannosidase activity in CSF.

artículo científico publicado en 2017

Parkinson's and Lewy body dementia CSF biomarkers

artículo científico publicado en 2019

Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies.

artículo científico publicado en 2015

The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease

artículo científico publicado en 2019

Lista de obras de

Accumulation of free oligosaccharides and tissue damage in cytosolic α-mannosidase (Man2c1)-deficient mice.

CSF and blood biomarkers for Parkinson's disease

Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies

Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis.

Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease

Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients.

Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy Bodies

Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis

Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease.

Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid

Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid

First pilot newborn screening for four lysosomal storage diseases in an Italian region: identification and analysis of a putative causative mutation in the GBA gene

Identification of two novel beta-mannosidosis-associated sequence variants: biochemical analysis of beta-mannosidase (MANBA) missense mutations

Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease

Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links.

Lysosomal alpha-mannosidase and alpha-mannosidosis.

Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies

Lysosomal enzymes in PD: further evidence is needed

Molecular cloning and structural organization of the gene encoding the mouse lysosomal di-N-acetylchitobiase (ctbs).

Novel CSF biomarkers to discriminate FTLD and its pathological subtypes

Origin of α-mannosidase activity in CSF.

Parkinson's and Lewy body dementia CSF biomarkers

Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies.

The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease